(Q72429394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: a controlled 6-month clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

1 reference

E V Benenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

O B Timina

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 March 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

54-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

Proresid in the long-term treatment of rheumatoid arthritis

26 October 2019

cites work

1 reference

12 December 2020

A randomized controlled trial of ciamexon versus placebo in the immunomodulatory treatment of rheumatoid arthritis

1 reference

12 December 2020

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

1 reference

12 December 2020

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

1 reference

12 December 2020

Weekly intravenous methotrexate in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Immunological treatment of rheumatoid arthritis

1 reference

12 December 2020

Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment

1 reference

12 December 2020

Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study

1 reference

12 December 2020

Methotrexate--the rapidly acting drug

1 reference

12 December 2020

Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis.

1 reference

12 December 2020

Treatment of rheumatoid arthritis with higher dose intravenous methotrexate.

1 reference

12 December 2020

High dose intravenous methotrexate with leucovorin rescue in rheumatoid arthritis

1 reference

12 December 2020

Immunocorrection in rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02229866

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8187445%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference